Related Experiment Video
Updated: Aug 8, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Deep vein thrombosis outcome and the level of oral anticoagulation therapy
J A Caprini1, J I Arcelus, J J Reyna
1Departments of Surgery, Evanston Northwestern Healthcare and Northwestern University Medical School, Evanson, Illinois, USA
Insights
Maintaining a higher international normalized ratio (INR) during warfarin therapy improves deep vein thrombosis (DVT) resolution. Achieving therapeutic INR levels minimizes incomplete DVT resolution and chronic venous insufficiency symptoms.
Area of Science:
- Vascular Medicine
- Hematology
- Thrombosis Research
Background:
- Deep vein thrombosis (DVT) affects numerous patients, necessitating effective anticoagulation strategies.
- Warfarin is a common oral anticoagulant, but optimal therapeutic ranges for DVT resolution require further investigation.
Purpose of the Study:
- To evaluate the rate of deep vein thrombosis (DVT) resolution.
- To assess DVT outcomes based on achieved international normalized ratio (INR) levels during warfarin therapy.
Main Methods:
- A prospective study followed 33 patients (35 limbs) with acute symptomatic DVT for 1 year.
- Patients received initial heparin followed by 6 months of warfarin targeting an INR of 2.0-3.0.
- Venous duplex scanning and physical examinations were performed at multiple time points.
Main Results:
- Complete DVT resolution occurred in 68% of patients over 1 year.
- Higher median INR values correlated with complete DVT resolution at 1, 3, and 6 months.
- Occlusive thrombi were linked to incomplete resolution and higher rates of chronic venous insufficiency.
Conclusions:
- A significant proportion of DVTs remain unresolved despite 6 months of anticoagulation.
- Maintaining INR levels between 2.0 and 3.0 appears crucial for optimizing DVT resolution.
- Achieving and maintaining therapeutic INR levels may reduce the incidence of incomplete DVT resolution and subsequent complications.
Objective:
The purpose of this study was to assess the rate of deep vein thrombosis (DVT) resolution and DVT outcomes as functions of the level of oral anticoagulation therapy achieved with warfarin.
Methods:
In 33 consecutive patients, a series of 35 limbs with acute symptomatic DVT was followed throughout 1 year of anticoagulation therapy. All the patients underwent 5 days of intravenous unfractionated sodium heparin therapy that was adjusted in dose to prolong the activated thromboplastin time to 2.0 to 2.5 times the control. In addition, warfarin was administered for a period of 6 months, with a target international normalized ratio (INR) between 2.0 and 3.0. All the patients underwent venous duplex scanning and physical examination at the time of diagnosis and at 1 week, 1 month, 3 months, 6 months, and 1 year.
Results:
At the end of the 1-year study period, the rate of complete DVT resolution was 68%. The median INR values in patients with complete DVT resolution were significantly higher than those of patients with incomplete DVT resolution after 1, 3, and 6 months of treatment with warfarin. In addition, the proportion of patients with INR values below therapeutic range was significantly higher in patients with incomplete DVT resolution than in patients with complete DVT resolution after 1, 3, and 6 months of treatment with warfarin. The presence of occlusive thrombi was associated with incomplete DVT resolution. Of the patients with occlusive thrombi, 62% had chronic venous insufficiency symptoms develop, whereas only 11% of the patients with nonocclusive thrombi (P =.003) had these symptoms develop.
Conclusion:
Despite 6 months of oral anticoagulant therapy, almost one third of thrombi did not resolve completely. The INR values were significantly higher in those patients with complete DVT resolution. These results suggest that the maintenance of an INR level between 2.0 and 3.0 throughout oral anticoagulation therapy will minimize the rate of incomplete DVT resolution.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management

